Low MiR-187 Expression Promotes Resistance to Chemoradiation Therapy In Vitro and Correlates with Treatment Failure in Patients with Esophageal Adenocarcinoma-Reference-Cited by-同舟云学术

Low MiR-187 Expression Promotes Resistance to Chemoradiation Therapy In Vitro and Correlates with Treatment Failure in Patients with Esophageal Adenocarcinoma

Published:2016-01 Issue:1 Volume:22 Page:388-397
ISSN:1076-1551
Container-title:Molecular Medicine
language:en
Short-container-title:Mol Med

Author:

Lynam-Lennon Niamh,Bibby Becky A S,Mongan Ann Marie,Marignol Laure,Paxton Christian N,Geiersbach Katherine,Bronner Mary P,O’Sullivan Jacintha,Reynolds John V,Maher Stephen G

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.2119/molmed.2016.00020.pdf

Reference47 articles.

1. Arnold M, Soerjomataram I, Ferlay J, Forman D. (2015) Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 64:381–7.

2. Pennathur A, Gibson MK, Jobe BA, Luketich JD. (2013) Oesophageal carcinoma. Lancet. 381:400–12.

3. Thrift AP, Whiteman DC. (2012) The incidence of esophageal adenocarcinoma continues to rise: Analysis of period and birth cohort effects on recent trends. Ann. Oncol. 23:3155–62.

4. Murphy TJ, Ravi N, Reynolds JV. (2008) Treatment options for esophageal cancer. Expert Opin. Pharmacother. 9:3197–210.

5. Reynolds JV, et al. (2007) Long-term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer. Ann. Surg. 245:707–16.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complement is increased in treatment resistant rectal cancer and modulates radioresistance.;Cancer Letters;2024-09

2. Multi-omics approaches for biomarker discovery in predicting the response of esophageal cancer to neoadjuvant therapy: A multidimensional perspective;Pharmacology & Therapeutics;2024-02

3. Non-coding RNAs in radiotherapy resistance: Roles and therapeutic implications in gastrointestinal cancer;Biomedicine & Pharmacotherapy;2023-05

4. Noncoding RNAs in esophageal cancer: A glimpse into implications for therapy resistance;Pharmacological Research;2023-02

5. Chemotherapy to potentiate the radiation-induced immune response;Ionizing Radiation and the Immune Response - Part A;2023